AAAAAA

   
Results: 1-25 |
Results: 25

Authors: VANLAAR T VANHILTEN B NEEF C RUTGERS AWF PAVEL S BRUIJN JA
Citation: T. Vanlaar et al., THE ROLE OF EDTA IN PROVOKING ALLERGIC REACTIONS TO SUBCUTANEOUS INFUSION OF APOMORPHINE IN PATIENTS WITH PARKINSONS-DISEASE - A HISTOLOGIC-STUDY, Movement disorders, 13(1), 1998, pp. 52-55

Authors: VANLAAR T LAMMERS GJ ROOS RAC GERRITSEN JJ MEINDERS AE
Citation: T. Vanlaar et al., ANTIPARKINSONIAN DRUGS CAUSING INAPPROPRIATE ANTIDIURETIC-HORMONE SECRETION, Movement disorders, 13(1), 1998, pp. 176-178

Authors: VANLAAR T VANDERGEEST R DANHOF M BODDE HE GOOSSENS PH ROOS RAC
Citation: T. Vanlaar et al., STEPWISE INTRAVENOUS-INFUSION OF APOMORPHINE TO DETERMINE THE THERAPEUTIC WINDOW IN PATIENTS WITH PARKINSONS-DISEASE, Clinical neuropharmacology, 21(3), 1998, pp. 152-158

Authors: VANDERGEEST R VANLAAR T KRUGER PP GUBBENSSTIBBE JM BODDE HE ROOS RAC DANHOF M
Citation: R. Vandergeest et al., PHARMACOKINETICS, ENANTIOMER INTERCONVERSION, AND METABOLISM OF R-APOMORPHINE IN PATIENTS WITH IDIOPATHIC PARKINSONS-DISEASE, Clinical neuropharmacology, 21(3), 1998, pp. 159-168

Authors: DANHOF M VANDERGEEST R VANLAAR T BODDE HE
Citation: M. Danhof et al., AN INTEGRATED PHARMACOKINETIC-PHARMACODYNAMIC APPROACH TO OPTIMIZATION OF R-APOMORPHINE DELIVERY IN PARKINSONS-DISEASE, Advanced drug delivery reviews, 33(3), 1998, pp. 253-263

Authors: VANDERGEEST R KRUGER P GUBBENSSTIBBE JM VANLAAR T BODDE HE DANHOF M
Citation: R. Vandergeest et al., ASSAY OF R-APOMORPHINE, S-APOMORPHINE, APOCODEINE, ISOAPOCODEINE AND THEIR GLUCURONIDE AND SULFATE CONJUGATES IN PLASMA AND URINE OF PATIENTS WITH PARKINSONS-DISEASE, Journal of chromatography B. Biomedical sciences and applications, 702(1-2), 1997, pp. 131-141

Authors: VANDERGEEST R VANLAAR T GUBBENSSTIBBE JM BODDE HE DANHOF M
Citation: R. Vandergeest et al., IONTOPHORETIC DELIVERY OF APOMORPHINE II - AN IN-VIVO STUDY IN PATIENTS WITH PARKINSONS-DISEASE, Pharmaceutical research, 14(12), 1997, pp. 1804-1810

Authors: VANHILTEN JJ WAGEMANS EAH GHAFOERKHAN SF VANLAAR T
Citation: Jj. Vanhilten et al., MOVEMENT CHARACTERISTICS IN PARKINSONS-DISEASE - DETERMINATION OF DOPAMINERGIC RESPONSIVENESS AND THRESHOLD, Clinical neuropharmacology, 20(5), 1997, pp. 402-408

Authors: TERLETH C VANLAAR T SCHOUTEN R VANSTEEG H HODEMAEKERS H WORMHOUDT T CORNELISSENSTEIJGER PDM ABRAHAMS PJ VANDEREB AJ
Citation: C. Terleth et al., A LACK OF RADIATION-INDUCED ORNITHINE DECARBOXYLASE ACTIVITY PREVENTSENHANCED REACTIVATION OF HERPES-SIMPLEX VIRUS AND IS LINKED TO NONCANCER PRONENESS IN XERODERMA-PIGMENTOSUM PATIENTS, Cancer research, 57(19), 1997, pp. 4384-4392

Authors: VANLAAR T NEEF C DANHOF M ROON KI ROOS RAC
Citation: T. Vanlaar et al., A NEW SUBLINGUAL FORMULATION OF APOMORPHINE IN THE TREATMENT OF PATIENTS WITH PARKINSONS-DISEASE, Movement disorders, 11(6), 1996, pp. 633-638

Authors: WOLTERS EC TESSELAAR HJM BUSSEMAKER FEAM DAMMERS JWHH HAAS JA HORSTINK MWIM JANSEN ENH KORTEN JJ LAKKE JPWF DECOUL AAWO PEPERKAMP JPC ROOS RAC RUTGERS AWF TIJSSEN CC VANDERZWAN A VANLAAR T VANLEUSDEN JA VANROSSUM J VERBIEST HBC VERMEIJ AJ BAKHEIT J BATES D CAPILDEO R CHAND J KENNEDY P LEES A PARK D STURMAN S TURJANSKI N WILLIAMS A
Citation: Ec. Wolters et al., INTERNATIONAL (NL-UK) DOUBLE-BLIND-STUDY OF SINEMET CR AND STANDARD SINEMET (25 100) IN 170 PATIENTS WITH FLUCTUATING PARKINSONS-DISEASE/, Journal of neurology, 243(3), 1996, pp. 235-240

Authors: STEEGENGA WT VANLAAR T RITECO N MANDARINO A SHVARTS A VANDEREB AJ JOCHEMSEN AG
Citation: Wt. Steegenga et al., ADENOVIRUS E1A PROTEINS INHIBIT ACTIVATION OF TRANSCRIPTION BY P53, Molecular and cellular biology, 16(5), 1996, pp. 2101-2109

Authors: SHVARTS A STEEGENGA WT RITECO N VANLAAR T DEKKER P BAZUINE M VANHAM RCA VANOORDT WV HATEBOER G VANDEREB AJ JOCHEMSEN AG
Citation: A. Shvarts et al., MDMX - A NOVEL P53-BINDING PROTEIN WITH SOME FUNCTIONAL-PROPERTIES OFMDM2, EMBO journal, 15(19), 1996, pp. 5349-5357

Authors: VANLAAR T SCHOUTEN R JOCHEMSEN AG TERLETH C VANDEREB AJ
Citation: T. Vanlaar et al., TEMPERATURE-SENSITIVE MUTANT P53 (ALA143) INTERFERES TRANSIENTLY WITHDNA-SYNTHESIS AND CELL-CYCLE PROGRESSION IN SAOS-2 CELLS, Cytometry, 25(1), 1996, pp. 21-31

Authors: ARNOLDUS EPJ VANLAAR T
Citation: Epj. Arnoldus et T. Vanlaar, A REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME, The New England journal of medicine, 334(26), 1996, pp. 1745-1745

Authors: STEEGENGA WT SHVARTS A VANLAAR T VANDEREB AJ JOCHEMSEN AG
Citation: Wt. Steegenga et al., ALTERED PHOSPHORYLATION AND OLIGOMERIZATION OF P53 IN ADENOVIRUS TYPE12-TRANSFORMED CELLS, Oncogene, 11(1), 1995, pp. 49-57

Authors: ABRAHAMS PJ SCHOUTEN R VANLAAR T HOUWELING A TERLETH C VANDEREB AJ
Citation: Pj. Abrahams et al., DIFFERENT REGULATION OF P53 STABILITY IN UV-IRRADIATED NORMAL AND DNA-REPAIR DEFICIENT HUMAN-CELLS, Mutation research. DNA repair, 336(2), 1995, pp. 169-180

Authors: VANLAAR T JANSEN ENH NEEF C DANHOF M ROOS RAC
Citation: T. Vanlaar et al., PHARMACOKINETICS AND CLINICAL EFFICACY OF RECTAL APOMORPHINE IN PATIENTS WITH PARKINSONS-DISEASE - A STUDY OF 5 DIFFERENT SUPPOSITORIES, Movement disorders, 10(4), 1995, pp. 433-439

Authors: STEEGENGA WT VANLAAR T SHVARTS A TERLETH C VANDEREB AJ JOCHEMSEN AG
Citation: Wt. Steegenga et al., DISTINCT MODULATION OF P53 ACTIVITY IN TRANSCRIPTION AND CELL-CYCLE REGULATION BY THE LARGE (54 KDA) AND SMALL (21 KDA) ADENOVIRUS E1B PROTEINS, Virology, 212(2), 1995, pp. 543-554

Authors: VANLAAR T STEEGENGA WT JOCHEMSEN AG TERLETH C VANDEREB AJ
Citation: T. Vanlaar et al., GM1492 HUMAN-DIPLOID SKIN FIBROBLASTS LACK THE P53-DEPENDENT G1 CELL-CYCLE CHECKPOINT, Biochemical and biophysical research communications, 217(3), 1995, pp. 769-776

Authors: VANLAAR T STEEGENGA WT JOCHEMSEN AG TERLETH C VANDEREB AJ
Citation: T. Vanlaar et al., BLOOMS SYNDROME CELLS GM1492 LACK DETECTABLE P53 PROTEIN BUT EXHIBIT NORMAL G1 CELL-CYCLE ARREST AFTER UV IRRADIATION, Oncogene, 9(3), 1994, pp. 981-983

Authors: HOFSTEE DJ NEEF C VANLAAR T JANSEN ENH
Citation: Dj. Hofstee et al., PHARMACOKINETICS OF APOMORPHINE IN PARKINSONS-DISEASE - PLASMA AND CEREBROSPINAL-FLUID LEVELS IN RELATION TO MOTOR-RESPONSES, Clinical neuropharmacology, 17(1), 1994, pp. 45-52

Authors: NEEF C JELLIFFE RW VANLAAR T LOOHUIS T ESSINK AWG JANSEN ENH
Citation: C. Neef et al., POPULATION PHARMACOKINETICS OF APOMORPHINE IN PATIENTS WITH PARKINSONS-DISEASE, Drug investigation, 7(4), 1994, pp. 183-190

Authors: VANLAAR T JANSEN ENH ESSINK AWG NEEF C OOSTERLOO S ROOS RAC
Citation: T. Vanlaar et al., A DOUBLE-BLIND-STUDY OF THE EFFICACY OF APOMORPHINE AND ITS ASSESSMENT IN OFF-PERIODS IN PARKINSONS-DISEASE, Clinical neurology and neurosurgery, 95(3), 1993, pp. 231-235

Authors: VANDENHEUVEL SJL VANLAAR T THE I VANDEREB AJ
Citation: Sjl. Vandenheuvel et al., LARGE E1B PROTEINS OF ADENOVIRUS TYPE-5 AND TYPE-12 HAVE DIFFERENT EFFECTS ON P53 AND DISTINCT ROLES IN CELL-TRANSFORMATION, Journal of virology, 67(9), 1993, pp. 5226-5234
Risultati: 1-25 |